Ipca Laboratories Limited
IPCALAB
Rangering i aksjer
#3409
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Aksjekurs
$20.02
Sist synkronisert: 2026-10-19
Markedsverdi
$5.08B
Endring (1 dag)
-1.65%
Endring (1 år)
38.46%
Land
IN
Handel Ipca Laboratories Limited (IPCALAB)
Kategori
Healthcare
Utbyttehistorikk for Ipca Laboratories Limited (IPCALAB)
Ipca Laboratories Limited (aksjesymbol: IPCALAB) har gitt totalt 44 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $40.15
Utbytteavkastning (TTM): 0.0031
Summen av alle utbytter (justert for aksjesplitt): $40.15
Utbytteavkastning (TTM): 0.0031
Utbyttebetalinger for Ipca Laboratories Limited (IPCALAB) fra 1999 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $2.00 | 0.00% |
| 2025 | $2.00 | -50.00% |
| 2024 | $4.00 | 100.00% |
| 2023 | $2.00 | -50.00% |
| 2022 | $4.00 | 0.00% |
| 2021 | $4.00 | -38.46% |
| 2020 | $6.50 | 333.33% |
| 2019 | $1.50 | 200.00% |
| 2018 | $0.5 | 0.00% |
| 2017 | $0.5 | 0.00% |
| 2015 | $0.5 | -60.00% |
| 2014 | $1.25 | -44.44% |
| 2013 | $2.25 | 7.14% |
| 2012 | $2.10 | 31.25% |
| 2011 | $1.60 | 14.29% |
| 2010 | $1.40 | 16.67% |
| 2009 | $1.20 | 41.18% |
| 2008 | $0.85 | 13.33% |
| 2007 | $0.75 | 15.38% |
| 2006 | $0.65 | 18.18% |
| 2005 | $0.55 | 0.00% |
| 2004 | $0.55 | -21.43% |
| 2003 | $0.7 | 154.55% |
| 2002 | $0.275 | 266.67% |
| 2001 | $0.075 | -75.00% |
| 2000 | $0.3 | 100.00% |
| 1999 | $0.15 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $2.00 | 0.00% |
| 2025 | $2.00 | -50.00% |
| 2024 | $4.00 | 100.00% |
| 2023 | $2.00 | -50.00% |
| 2022 | $4.00 | -50.00% |
| 2021 | $8.00 | -38.46% |
| 2020 | $13.00 | 333.33% |
| 2019 | $3.00 | 200.00% |
| 2018 | $1.00 | 0.00% |
| 2017 | $1.00 | 0.00% |
| 2015 | $1.00 | -60.00% |
| 2014 | $2.50 | -44.44% |
| 2013 | $4.50 | 7.14% |
| 2012 | $4.20 | 31.25% |
| 2011 | $3.20 | -46.67% |
| 2010 | $6.00 | -50.00% |
| 2009 | $12.00 | 41.18% |
| 2008 | $8.50 | 13.33% |
| 2007 | $7.50 | 15.38% |
| 2006 | $6.50 | 18.18% |
| 2005 | $5.50 | -50.00% |
| 2004 | $11.00 | -21.43% |
| 2003 | $14.00 | 154.55% |
| 2002 | $5.50 | 266.67% |
| 2001 | $1.50 | -75.00% |
| 2000 | $6.00 | 140.00% |
| 1999 | $2.50 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
